Pharmaceuticals & Medical Research

By Manojna Maddipatla and Emma Farge GENEVA (Reuters) -Discarded syringes, used test kits and old vaccine bottles from the COVID-19...

TOKYO (Reuters) - Japanese trading and pharmaceuticals company Kowa Co Ltd on Monday said that anti-parasite drug ivermectin showed an...

SYDNEY (Reuters) -Australia suffered its deadliest day of the COVID-19 pandemic on Friday with nearly 100 deaths, but several large...

By Alistair Smout and Elizabeth Piper LONDON (Reuters) -After an uncomfortable but relatively brief return to coronavirus restrictions triggered by...

By Emma Farge GENEVA (Reuters) - The Omicron-fuelled wave of COVID-19 infections has led wealthy countries to intensify their recruitment...

By Francesco Guarascio BRUSSELS (Reuters) - Influenza has returned to Europe at a faster-than-expected rate this winter after almost disappearing...

By Pushkala Aripaka and Ludwig Burger (Reuters) -AstraZeneca said on Thursday that preliminary data from a trial showed that its...

SANTIAGO (Reuters) - Chile will begin offering a fourth shot of the coronavirus vaccine next week to immunocompromised citizens, the...

HAVANA (Reuters) - Cuba tightened border controls on Wednesday as the Caribbean island nation moved to tamp down a growing...

By Mike Scarcella (Reuters) - A U.S. appeals court on Tuesday revived a lawsuit against AstraZeneca Plc, Pfizer Inc and...

By Gram Slattery and Augustin Geist RIO DE JANEIRO/BUENOS AIRES (Reuters) - Throughout much of 2020 and early 2021, South...

BENGALURU (Reuters) - India has approved Merck's COVID-19 pill and two more vaccines for emergency use as the world's second...

DUBAI (Reuters) - The United Arab Emirates has approved emergency use of Sinopharm's protein-based COVID-19 vaccine and it will be...

ABUJA (Reuters) - The Nigerian president's top media aide Garba Shehu said on Saturday that he has tested positive for...

By Nancy Lapid (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that...

By Reuters Staff PARIS (Reuters) - France has cancelled its order for Merck & Co's COVID-19 antiviral drug following disappointing...

(Reuters) - Merck & Co Inc has signed deals to sell about 9 million courses of its experimental COVID-19 pill...

By Francesco Guarascio and Pushkala Aripaka (Reuters) - The Serum Institute of India (SII) has waived its protection from legal...

By Nancy Lapid (Reuters) - The following is a summary of some recent studies on COVID-19. They include research that...

By Emma Farge GENEVA (Reuters) -The World Health Organization's European head on Tuesday warned countries to brace for a "significant...